- €6.25bn
- €7.30bn
- €343.70m
- 37
- 61
- 88
- 69
R2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Interim Report | ARS | ARS | ARS | ARS |
Standards: | — | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 4,681 | 3,660 | 4,493 | 4,640 | 344 |
Cost of Revenue | |||||
Gross Profit | 2,689 | 2,259 | 2,822 | 2,985 | 249 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 4,323 | 3,609 | 2,270 | 3,673 | -1,568 |
Operating Profit | 357 | 51 | 2,224 | 967 | 1,911 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 147 | -269 | 1,983 | 573 | 1,858 |
Provision for Income Taxes | |||||
Net Income After Taxes | 122 | -290 | 1,883 | 489 | 1,853 |
Minority Interest | |||||
Equity in Affiliates | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 113 | -160 | 1,570 | 595 | 1,824 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 113 | -160 | 1,570 | 595 | 1,824 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 4.15 | 2.81 | 23.2 | 9.94 | -0.017 |
Dividends per Share |